Supercharge Your Innovation With Domain-Expert AI Agents!

Anti-depression drug and application thereof

An antidepressant, drug technology, applied in the field of medicine

Active Publication Date: 2019-04-23
山东肽莱生物制药有限公司
View PDF6 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are still no studies and reports on the use of uninhibited terpenes for depression

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-depression drug and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0075] Example 1 Unkissed terpene tablet for antidepressant

[0076] Untethered terpene 100g

[0077] Hypromellose 24g

[0078] Lactose 9g

[0079] Povidone K30 6g

[0080] Magnesium Stearate 10g

[0081] Talc powder 2.7g

[0082] (1) Weigh the prescribed amount of terpene, hypromellose and lactose and mix them evenly as a medicine powder;

[0083] (2) Weigh the prescribed amount of povidone K30 and add water to prepare a povidone K30 aqueous solution with a mass concentration of 3%, add the povidone K30 aqueous solution to the powder for wet granulation, pass the wet granules through a 20-mesh sieve, and dry at 60°C for 1.5 hours Sieve through a 20-mesh sieve;

[0084] (3) Add the prescribed amount of magnesium stearate and talcum powder to the granules obtained from the whole granulation, and compress them into 1000 tablets.

Embodiment 2

[0085] Example 2 Unbound terpene pachylic acid A compound tablet for antidepressant

[0086] Untethered Terpene 80g

[0087] Pachymic Acid A 40g

[0088] Hypromellose 24g

[0089] Lactose 9g

[0090] Povidone K30 7g

[0091] Magnesium Stearate 10g

[0092] Talc powder 3g

[0093] (1) Weigh the prescription amount of terpene, pachymic acid A, hypromellose and lactose and mix them uniformly as a medicinal powder;

[0094] (2) Weigh the prescribed amount of povidone K30 and add water to prepare a povidone K30 aqueous solution with a mass concentration of 3%, add the povidone K30 aqueous solution to the powder for wet granulation, pass the wet granules through a 20-mesh sieve, and dry at 60°C for 1.5 hours Sieve through a 20-mesh sieve;

[0095] (3) Add the prescribed amount of magnesium stearate and talcum powder to the granules obtained from the whole granulation, and compress them into 1000 tablets.

Embodiment 3

[0096] Example 3 Unbound terpene pachylic acid A compound tablet for antidepressant

[0097] Untethered Terpene 80g

[0098] Pachymic Acid A 20g

[0099] Hypromellose 24g

[0100] Lactose 9g

[0101] Povidone K30 6g

[0102] Magnesium Stearate 10g

[0103] Talc powder 2.7g

[0104] (1) Weigh the prescription amount of terpene, pachymic acid A, hypromellose and lactose and mix them uniformly as a medicinal powder;

[0105] (2) Weigh the prescribed amount of povidone K30 and add water to prepare a povidone K30 aqueous solution with a mass concentration of 3%, add the povidone K30 aqueous solution to the powder for wet granulation, pass the wet granules through a 20-mesh sieve, and dry at 60°C for 1.5 hours Sieve through a 20-mesh sieve;

[0106] (3) Add the prescribed amount of magnesium stearate and talcum powder to the granules obtained from the whole granulation, and compress them into 1000 tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of drugs, and particularly relates to an anti-depression drug and application thereof. The active ingredients of the anti-depression drug at least comprise friedelin, preferably, the active ingredients of the anti-depression drug include the friedelin and pachymic acid A. When the friedelin and the pachymic acid A are used as a composition, the weight part ratioof the the friedelin to the pachymic acid A in the anti-depression drug is (2-4):1. Oral tablets are preferably selected as the form of the anti-depression drug. The accessories of the oral tablets comprise hydroxypropyl methylcellulose, lactose, povidone K30, magnesium stearate and talcum powder. The drug has an improvement effect on the behavioral features, caused by chronic unpredictable mild stress, of a rat depression model.

Description

technical field [0001] The invention belongs to the field of drugs, and in particular relates to an antidepressant drug and its application. Background technique [0002] Depression is a mental disorder that seriously plagues human mental activities. Patients usually manifest as depressed mood, lack of interest in things, and suicidal tendencies. Accelerated pace of social life and excessive mental stress are considered to be social factors that induce depression. At least for now, the acceleration of the industrialization process is indeed accompanied by an increase in the incidence of depression. According to statistics, in the context of the global population, the lifetime prevalence rate of depression is as high as 5.2% to 16.2%, among which the incidence rate of women is particularly prominent. It is speculated that the prevalence of depression in mainland China may reach 7% to 8%, and the trend of younger people is obvious. According to the statistics and predictio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/56A61K31/575A61P25/24
CPCA61K31/56A61K31/575A61P25/24A61K2300/00
Inventor 张凤田孙丽丽孙益虎
Owner 山东肽莱生物制药有限公司
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com